Idiopathic pulmonary hemosiderosis - a diagnostic challenge
© Bakalli et al.; licensee BioMed Central Ltd. 2014
Received: 29 January 2014
Accepted: 28 March 2014
Published: 4 April 2014
Idiopathic pulmonary hemosiderosis is a rare disorder that can occur at any age and is characterized by the triad of hemoptysis, iron deficiency anemia and diffuse pulmonary infiltrates. The clinical course is exceedingly variable especially in children and a substantial proportion of this age group is undiagnosed. It is probably due to the fact that iron deficiency anemia may be the first and the only manifestation of IPH, preceding other symptoms and signs by several months and IPH is not considered as a rare cause of anemia, unless the typical triad is present. We present a case of IPH in a 13-year-old girl, treated for several months with persistent iron deficiency anemia, without response to therapy.
KeywordsPulmonary hemosiderosis Anemia Children
Idiopathic pulmonary hemosiderosis (IPH) is a rare and life threatening condition, found primarily in children, that causes recurrent episodes of diffuse alveolar hemorrhage. It is characterized by hemoptysis, alveolar infiltrates on chest radiograph and various degrees of anemia, seen more frequently in children than in adults [1–7]. The estimated incidence of IPH in children is 0.24–1.23 cases per million, with a mortality rate as high as 50%. Only 500 cases have been described in medical literature [3, 6, 8]. When no underlying cause for repeated episodes of diffuse alveolar hemorrhage is apparent, the entity is referred to as idiopathic pulmonary hemosiderosis . The rarity of this disease and the variable clinical course results in many diagnostic pitfalls especially in children . Late diagnosis of IPH may allow complications and the beginning of treatment at a stage when pulmonary fibrosis has already developed, with consequently poorer prognosis [2, 10]. Through our presentation we want to emphasize the importance of early recognition of this syndrome.
Laboratory investigations revealed negative work-up for antinuclear antibodies (ANA), antineutrophil cytoplasmic antibodies (ANCA), rheumatoid factor, anti-citrullinated peptides (anti-CCP), antiglomerular basement membrane (antiGBM), antigliadin, specific cow’s milk IgE and complement. Therapy with corticosteroids was initiated with a partial and transient response. The girl presented with recurrent episodes of dyspnea and severe anemia every two-three months. Due to prolonged therapy, the girl has become progressively cushingoid. Azathioprine, the “second line” immunosuppressant recommended in IPH , was subsequently introduced. Now clinical situation is better controlled.
The triad of iron deficiency anemia, hemoptysis and diffuse infiltrates on chest - X ray, characterizes the onset of IPH. However, any of these features may be the first presenting manifestation and the clinical course is exceedingly variable especially in children [11, 12]. So, from a Romanian experience of 15 children diagnosed with IPH during a 22-year period (1984–2006), the classical triad was found in only 4 cases . On the other hand all patients, from the beginning had anemia and only 6 children presented with pulmonary symptoms. Even in the French RespiRare® cohort anemia and dyspnea were the most frequent clinical features at the beginning (64% and 68% respectively), while hemoptysis occurred only in 50% of the patients .
The age of presentation is bimodal, with a frequency peaks in children less than five years of age and in adolescents 11 years or older.
A substantial proportion of the first group is undiagnosed. It is probably due to not only to the lack of hemoptysis, but to the fact that iron deficiency anemia may be the first and the only manifestation of IPH, preceding other symptoms and signs by several months [3, 4, 13, 14]. Iron deficiency anemia is the most common hematologic disorder seen in childhood and IPH is not considered as a rare cause of anemia, unless the typical triad is present [3, 15].
Anemia in these cases is classical of iron deficiency, hypochromic microcytic, due to chronic loss of blood. But if in iron deficiency anemia, hematologic response to iron is usually remarkable within the first month of therapy, therapy failed during hemosyderosis . As in our case, no response to therapy and need for several transfusions has been reported even in other cases [15–21]. Failure of iron therapy and exclusion of its common causes, prompt us to look at other diagnostic possibilities including IPH, even it is a rare cause.
If bleeding is not substantial, pulmonary involvement may not been found clinically at the beginning of the disease and even chest X-ray may present normal, but with the development of the disease, roentgenographic manifestations, once abnormal, never return to normal although acute massive infiltration partially resolve, making chest X-ray very useful in such cases . Unfortunately, we don’t have a chest X ray of our case before the 2nd hospitalization.
IPH is a severe condition with variable prognosis and has a better outcome when diagnosis is made at an early age [3, 10, 15]. Due to the rarity of the disease and the variability in clinical presentation, diagnosis is usually delayed. (Several months in our case) Kipper et al. noted there is a long delay (4 moths–10 years) between the starting of symptoms and the time of correct diagnosis . A mean delay of 2.4 years before diagnosis was found in the Romanian experience and 30 months in the Indian experience [10, 19].
The gold standard for IPH diagnosis is lung biopsy . On the other hand, diagnosis of IPH can be confirmed by bronchoscopy with bronchoalveolar lavage, showing hemosiderin-laden macrophages [6, 23]. In our case confirmation of the diagnosis was made by the presence of siderophages in gastric lavage fluid, which is equally diagnostic and also the simplest, reliable test in infants and young children .
HR-CT scan are useful for early detection of pulmonary fibrosis. Aggressive therapy is imperative to avoid pulmonary fibrosis and mortality in these patients .
There are no evidence-based recommendations regarding the treatment of IPH. As indicated in small case series and/or case reports, corticosteroids are the mainstay treatment of IPH [10, 18]. It has been reported that corticosteroids are associated with decreased pulmonary bleeding relapses and pulmonary fibrosis [1, 4, 13]. Even though, there are controversial and lack clear evidence in their favor. Other studies suggest that they do not have any effect on the prognosis of this disease . In the Romanian experience treatment with corticosteroids alone was not effective in 12 of 15 children . Immunosuppressive therapies, mainly azathioprine and hydroxychloroquine, are mostly proposed in situations of patients with steroid-refractory disease [1, 23, 25]. In our case corticosteroids were partially effective. Clinical situation was better controlled with azathioprine in combination with corticosteroids.
Yoachimescu et al. also concluded that azathioprine in combination with corticosteroids might be the best therapeutic regimen, especially in preventing IPH exacerbations, as in our case .
According to the Indian experience, treatment with prednisolone and hydroxychloroquine were more effective in the clinical course and the survival .
A 2007 scientific letter, reports preliminary success in preventing pulmonary hemorrhage with the anti-oxidant N-acetylcysteine .
The IPH and ITP may have occurred coincidentally in this patient, but certain pathophysiological similarities between these two disorders suggests that they are related. In fact, according Mayo Clinic Internal Medicine, IPH has been described in association with ITP, autoimmune hemolytic anemia and celiac disease . Even though the etiology of IPH remains unknown, there is support for an autoimmune contribution in IPH physiopathology. In the French RespiRare® cohort most of the patients had autoimmune antibodies at onset or appeared during the follow-up. (Anti-smooth-muscle antibodies SMA – 50% of the tested patients, ANA – 45% and ANCA – 40%) . Work-up for autoimmune antibodies in our case resulted negative.
IPH prognosis seems to improve over time. While two decades ago the mean survival was 3 years from diagnosis, recent data show a 5-year survival in 86% of cases . The significant improvement is possibly due to the long-term use of immunosuppressant therapy.
IPH although a rare entity, should be considered in patients with long-term iron deficiency anemia. A chest X-ray is compulsory in every unexplained iron deficiency anemia exploration.
Pediatrician should keep in mind the possibility of pulmonary hemosiderosis, in case of very quick anemia, associated with early signs of respiratory failure.
Lack of hemoptysis does not exclude the diagnosis of pulmonary hemosiderosis.
Written informed consent was obtained from the patient’s parent for the publication of this report and any accompanying images.
Idiopathic pulmonary hemosiderosis
Idiopathic thrombocytopenic purpura
Red Blood Cells
Mean corpuscular hemoglobin
Mean corpuscular volume
Mean cell hemoglobin concentration
Antineutrophil cytoplasmic antibodies
Antiglomerular basement membrane
- HR-CT scan:
High resolution computed tomography scans.
- Taytard J, Nathan N, Blic J, Fayon M, Epaud R, Deschildre A, Troussier F, Lubrano M, Chiron R, Reix P, Cros P, Mahloul M, Michon D, Clement A, Corvol A: New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare® cohort. Orphanet J Rare Dis. 2013, 8: 161-10.1186/1750-1172-8-161.PubMed CentralView ArticlePubMedGoogle Scholar
- Kliegman RM, Behrman RE, Jenson HB, Stanton BF: Nelson Textbook of Pediatrics. 2007, USA: Saunders (Elsevier Science), 1824-1830. 18Google Scholar
- Kamienska E, Urasinski T, Gawlikowska-Sroka A, Glura B, Pogorzelski B: Idiopathic pulmonary hemosiderosis in a 9-year-old girl. Eur J Med Res. 2009, 14 (Suppl 4): 112-115.PubMed CentralPubMedGoogle Scholar
- Chen K, Hsiao CC, Huang SC, Ko SF, Niu CK: Anemia as the sole presenting symptom of idiopathic pulmonary hemosiderosis: report of two cases. Chang Gung Med J. 2004, 27: 824-829.PubMedGoogle Scholar
- Datta AK, Ghosh T, Ghosh MK, Nayak K, Das SK: Pediatric oncall. 2009, 6 (3): Available at: [http://www.pediatriconcall.com/Journal/Article/FullText.aspx?artid=63&type=J&tid=&imgid=&reportid=117&tbltype=]Google Scholar
- Khonglah Y, Raphael V, Bhuyan A, Gogoi P, Dass R: Idiopathic pulmonary haemosiderosis: diagnosis by gastric lavage. African Journal of Respiratory Medicine. 2013, 8 (2): 26-27.Google Scholar
- Napchan GD, Bye MR: Hemosiderosis. Last Updated: Apr 16, 2012. Available at: [http://emedicine.medscape.com/article/1002002-overview]
- Ioachimescu OC, Sieber S, Kotch A: Idiopathic pulmonary haemosiderosis revisited. Eur Respir J. 2004, 24: 162-170. 10.1183/09031936.04.00116302.View ArticlePubMedGoogle Scholar
- Yao TC, Hung IJ, Wong KS, Huang JL, Niu CK: Pitfalls in the diagnosis of idiopathic pulmonary haemosiderosis. Arch Dis Child. 2002, 86: 436-438. 10.1136/adc.86.6.436.PubMed CentralView ArticlePubMedGoogle Scholar
- Bulucea C, Sorin D: Idiopathic pulmonary hemosiderosis in children: a Romanian experience. Pediatrics. 2008, 121 Suppl: 158-159.View ArticleGoogle Scholar
- Idiopathic Pulmonary Haemosiderosis. Last updated: 15 March 2013. Available at: [http://en.wikipedia.org/wiki/Idiopathic_pulmonary_haemosiderosis]
- Willms H, Gutjahr K, Juergens UR, Hammerschmidt S, Gessner C, Hoheisel G, Wirtz H, Gillissen A: Diagnostics and therapy of idiopathic pulmonary hemosiderosis. Med Klin (Munich). 2007, 102 (6): 445-450. 10.1007/s00063-007-1057-9.View ArticleGoogle Scholar
- Poggi V, Vecchio A, Menna F, Menna G: Idiopathic pulmonary hemosiderosis: a rare cause of iron –deficiency anemia in childhood. J Pediatr Hematol Oncol. 2011, 33 (4): 160-162. 10.1097/MPH.0b013e318212a6df.View ArticleGoogle Scholar
- Ferrari GF, Fioretto JR, Adriano FR, Alves AF, Gicélia S, Brandão GS: Idiopathic pulmonary hemosiderosis: case report. J Pediatr (Rio J). 2000, 76 (2): 149-152. 10.2223/JPED.57.View ArticleGoogle Scholar
- Sankararaman S, Shah K, Maddox K, Velayuthan S, Scott LK: Clinical case of the month. Idiopathic pulmonary hemosiderosis presenting as a rare cause of iron deficiency anemia in a toddler--a diagnostic challenge. J La State Med Soc. 2012, 164 (5): 293-296.PubMedGoogle Scholar
- Idiopathic pulmonary hemosiderosis. Last updated: 1/29/2013. Available at: [http://rarediseases.info.nih.gov/gard/6763/idiopathic-pulmonary-hemosiderosis/resources/1]
- Erdağ GC, Vitrinel A, Mutlu GY, Akin Y, Sadikoğlu S, Kartal LK: Idiopathic pulmonary hemosiderosis- a case report. Marmara Medical Journal. 2006, 19 (1): 33-35.Google Scholar
- Rathi PS, Chetan G, Aggarwal R, Kini U, Rao B: Primary pulmonary hemosiderosis-a rare cause of microcytic hypochromic anemia. Curr Pediatr Res. 2011, 15 (1): 1-3.Google Scholar
- Afzal N, Mushtaq A, Rahman A, Qureshi S: Idiopathic pulmonary haemosiderosis presenting as severe iron deficiency anaemia–a case from Pakistan. J Pak Med Assoc. 2012, 62 (8): 845-847.PubMedGoogle Scholar
- Vishal G, Dalal E, Raval N: Idiopathic pulmonary haemosiderosis. Natl J Med Res. 2013, 3 (3): 292-293.Google Scholar
- Gilman PA, Zinkham WH: Severe idiopathic pulmonary hemosiderosis in the absence of clinical or radiologic evidence of pulmonary disease. J Pediatr. 1969, 75 (1): 118-121. 10.1016/S0022-3476(69)80110-1.View ArticlePubMedGoogle Scholar
- Kiper N, Göçmen A, Ozçelik U, Dilber E, Anadol D: Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979–1994): prolonged survival with low-dose corticosteroid therapy. Pediatr Pulmonol. 1999, 27 (3): 180-184. 10.1002/(SICI)1099-0496(199903)27:3<180::AID-PPUL5>3.0.CO;2-8.View ArticlePubMedGoogle Scholar
- Keller C, Langston C: Childhood idiopathic pulmonary hemosiderosis. N Engl J Med. 2000, 343: 781-10.1056/NEJM200009143431105.View ArticlePubMedGoogle Scholar
- Shah GS, Parakh P, Chalise S, Mehta K, Mishra OP: Idiopathic pulmonary hemosiderosis: a case report with review of related literature. J Clin Case Rep. 2012, 2: 12-View ArticleGoogle Scholar
- Kabra SK, Bhargava S, Lodha R, Satyavani A, Walia M: Idiopathic pulmonary hemosiderosis: clinical profile and follow up of 26 children. Indian Pediatr. 2007, 44 (5): 333-338.PubMedGoogle Scholar
- Habermann TM, Ghosh AK: Mayo Clinic Internal Medicine: Concise Textbook. 2007, Rochester, Minnesota, USA: CRC Press, 778-ISBN-10: 1420067494 | ISBN-13: 978-1420067491 | Edition: 1, 1View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.